Skip to main content
Clinical Trials/TCTR20180913004
TCTR20180913004Active, not recruiting未知

Midazolam Affects Cognitive Function in Elderly undergoing Radiofrequency Ablation

Facultyof Medicine0 sites90 target enrollmentStarted: September 13, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
65 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • - Patients treated with radiofrequency ablation to destroy the tumor. The radiation treatment unit and know that they have tumors on the liver.
  • - Patients aged 65-80 years
  • - Patients receiving education not lower than grade 6
  • - Patients can communicate in listening, speaking, reading and writing.
  • - ASA 1-3

Exclusion Criteria

  • - Have mental illness
  • - Have underlying disease such as;Alzheimer's disease, dementia, neurological deficit
  • - received the drug in the group. Antipsychotics, Regular sedative drugs
  • - allergy to sedative agents
  • - Preoperative neurological deficit such as Parkinson’s disease, Dementia, Vascular disease in the brain.
  • - History of alcohol.
  • - The function or routine of daily life is less.
  • - Malnutrition
  • - Elderly or very elderly. And hearing or vision defects.
  • - Dehydration, solution and electrolyte imbalance after surgery are sodium, potassium and glucose.
  • - Insomnia, not private location.
  • - On Foley’s catheter.
  • - Disorder of intellect and history of acute confusion.
  • - Hypoxia, hypoxemia and decrease level of Hb after operative.
  • - On Narcotic and Benzodiazepine medicine.
  • - Uncontrol postoperative pain.

Investigators

Sponsor
Facultyof Medicine

Similar Trials